Market Research Logo

Kuwait Pharmaceuticals and Healthcare Report Q2 2015


Attention: There is an updated edition available for this report.

Kuwait Pharmaceuticals and Healthcare Report Q2 2015

BMI View: While the persistence of lower oil prices will drive down national budgets and curtail someinvestment programmes, we maintain that the healthcare sector's perception as a critical source ofeconomic diversification away from hydrocarbons in addition to public support, will continue to be largelyinsulated from major cuts to funding. As such, drugmakers will continue see to sector values rise in allcategories, although patented prescription drugs will dominate in value terms. However, a continuedescalation of regional security concerns and to a lesser extent, internal political instability, will frustrateinvestors' ability to forecast the long-term direction of public spending and heighten the risk of sharpunexpected corrections to sales.

Headline Expenditure Projections

Pharmaceuticals: From KWD0.312bn (USD1.10bn) in 2014 to KWD0.334bn (USD1.13bn) in 2015;+7.0% in local currency terms and +2.8% in US dollar terms. Forecast down from Q115.

Healthcare: From KWD1.55bn (USD5.43bn) in 2014 to KWD1.68bn (USD5.66bn) in 2015; +8.3% inlocal currency terms and +4.3% in US dollar terms. Forecast unchanged from Q115.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kuwait 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Kuwait 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Kuwait 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Expenditure Breakdown
Table: Economic Activity (Kuwait 2010-2019)
Industry Risk Reward Ratings
Middle East And Africa Risk/Reward Index
Kuwait Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Healthcare Sector Developments
Healthcare Insurance
Research and Development
Regulatory Development
Regulatory Regime
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Competitive Landscape
Domestic Industry
Foreign Industry
Pharmaceutical Distribution
Company Profile
Pfizer
GlaxoSmithKline
Sanofi
Merck & Co
Johnson & Johnson
Novartis
Kuwait-Saudi Pharmaceutical Industries (KSP)
Advanced Technology Company
Bader Sultan & Bros
Safwan Trading And Contracting Company
Demographic Forecast
Table: Population Headline Indicators (Kuwait 1990-2025)
Table: Key Population Ratios (Kuwait 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Kuwait 1990-2025)
Table: Population By Age Group (Kuwait 1990-2025)
Table: Population By Age Group % (Kuwait 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report